Reduced parahippocampal and lateral temporal GABAA-[11C]flumazenil binding in major depression: preliminary results
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Purpose Major depressive disorder (MDD) has been related to both a dysfunctional gamma-amino butyric acid (GABA) system and to hyperactivity of the hypothalamic-pituitary-adrenal axis (HPA). Although GABA has been suggested to inhibit HPA axis activity, their relationship has never been studied at the level of the central GABA(A)-benzodiazepine receptor in depressed patients or in relation to antidepressant treatment. Methods Eleven depressed outpatients were compared, before and after treatment with citalopram, with nine age-matched healthy controls. The subjects were scanned using the positron emission tomography (PET) tracer [(11)C]flumazenil ([(11)C]FMZ). Parametric voxel-by-voxel Logan plots were compared with methods based on regions of interest (ROI), to provide volume of distribution (V(T)) and binding potential (BP(ND)) values. Plasma GABA levels were determined and a dexamethasone-corticotropin releasing hormone (DEX-CRH) test was performed. Results In MDD, parametric voxel-by-voxel Logan plots showed bilateral reduced [(11)C]FMZ binding in the parahippocampal gyrus and right lateral superior temporal gyrus (p uncorrected Conclusion The bilateral reduction in limbic parahippocampal and right temporal [(11)C]FMZ binding found in MDD indicates decreased GABA(A)-benzodiazepine receptor complex affinity and/or number. The inverse relationship between GABA(A) binding in the temporal lobe and HPA axis activity, suggests that HPA axis hyperactivity is partly due to reduced…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Likewise, reductions in both GABAA and GABAB receptor-mediated inhibition in MDD have been demonstrated across genomic [64], postmortem [65], and neuroimaging studies [28,48].”
From Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression (2023) · cites this paper as [48]
Citations
Cites
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032 · cited 1×
“Patients completed the Beck depression inventory (BDI) [30], the Hamilton anxiety rating scale (HAM-A) [31] and the Montgomery Åsberg depression rating scale (MADRS) [32].”
MethodA new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962 · cited 1×
“Patients completed the Beck depression inventory (BDI) [30], the Hamilton anxiety rating scale (HAM-A) [31] and the Montgomery Åsberg depression rating scale (MADRS) [32].”
MethodThe assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455 · cited 1×
“Patients completed the Beck depression inventory (BDI) [30], the Hamilton anxiety rating scale (HAM-A) [31] and the Montgomery Åsberg depression rating scale (MADRS) [32].”
Method(1976) · Medical Entomology and Zoology · Cited by 8,899
Multimodality image registration by maximization of mutual information
Maes, F., Collignon, A., Vandermeulen, D., Marchal, G., & Suetens, P. (1997) · IEEE Transactions on Medical Imaging · doi:10.1109/42.563664 · Cited by 4,547 · cited 1×
“MRI scans were coregistered with summed [C]FMZ images (10–60 min after injection) [38, 39].”
MethodStructured Clinical Interview for DSM-IV Axis I Disorders
Spitzer, R. L., First, M. B., & Gibbon, M. (1997) · Medical Entomology and Zoology · Cited by 4,086
Drevets, W. C., Price, J. L., & Furey, M. L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0189-x · Cited by 2,241 · cited 1×
“pathophysiology of depression and anxiety, that is the right temporal gyrus and the ventrolateral prefrontal cortex, indicating that high depression scores are related to low [ 11 C]FMZ binding [ 57 ].”
BackgroundSimplified Reference Tissue Model for PET Receptor Studies
Lammertsma, A. A., & Hume, S. P. (1996) · NeuroImage · doi:10.1006/nimg.1996.0066 · Cited by 2,021 · cited 1×
“ROI time–activity curves, VT, obtained using a single tissue (1T) compartment model with metabolite-corrected plasma input function and an additional parameter for blood volume, was compared with nondisplaceable binding potential (BPND) values obtained using the simplified reference tissue model (SRTM) [ 44 ] with the…”
MethodSelf-citationLogan, J., Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schlyer, D. J., MacGregor, R. R., Hitzemann, R., Bendriem, B., Gatley, S. J., et al. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.127 · Cited by 1,479
(2025) · Springer Reference Medizin · doi:10.1007/978-3-662-65186-5_300379 · Cited by 1,445
Mintun, M. A., Raichle, M. E., Kilbourn, M. R., Wooten, G. F., & Welch, M. J. (1984) · Annals of Neurology · doi:10.1002/ana.410150302 · Cited by 955 · cited 1×
“Here, BPND is the ratio of receptor density (Bmax) to radioligand equilibrium dissociation constant (KD) and is proportional to receptor density x affinity [46].”
BackgroundResampling-Based Multiple Testing.
Booth, J. G., Westfall, P. H., & Young, S. S. (1994) · Journal of the American Statistical Association · doi:10.2307/2291234 · Cited by 906
Comparison and Evaluation of Retrospective Intermodality Brain Image Registration Techniques
West, J., Fitzpatrick, J. M., Wang, M. Y., Dawant, B. M., Maurer, C. R., Kessler, R. M., Maciunas, R. J., Barillot, C., Lemoine, D., Collignon, A., et al. (1997) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199707000-00007 · Cited by 884 · cited 1×
“MRI scans were coregistered with summed [C]FMZ images (10–60 min after injection) [38, 39].”
MethodNonparametric Analysis of Statistic Images from Functional Mapping Experiments
Holmes, A. P., Blair, R. C., Watson, J. D. G., & Ford, I. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199601000-00002 · Cited by 873 · cited 1×
“Due to the large number of comparisons made, voxel-based analyses are susceptible to type I errors [63, 64].”
BackgroundHasler, G., van der Veen, J. W., Tumonis, T., Meyers, N., Shen, J., & Drevets, W. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.2.193 · Cited by 846
Subtype-Specific Alterations of γ-Aminobutyric Acid and Glutamatein Patients With Major Depression
Sanacora, G., Gueorguieva, R., Epperson, C. N., Wu, Y.-T., Appel, M., Rothman, D. L., Krystal, J. H., & Mason, G. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.705 · Cited by 796
Multi-modality image registration by maximization of mutual information
Maes, F., Collignon, A., Vandermeulen, D., Marchal, G., & Suetens, P. (1996) · Proceedings of the Workshop on Mathematical Methods in Biomedical Image Analysis · doi:10.1109/mmbia.1996.534053 · Cited by 795
Duvernoy, H. M. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6792-2 · Cited by 756
Kennedy, S. H., Evans, K. R., Krüger, S., Mayberg, H. S., Meyer, J. H., McCann, S., Arifuzzman, A. I., Houle, S., & Vaccarino, F. J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.6.899 · Cited by 710 · cited 1×
“[49] found diminished glucose uptake in (para)hippocampal regions in depression after successful treatment with paroxetine, suggesting normalization to baseline levels.”
BackgroundThe combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders
Heuser, I., Yassouridis, A., & Holsboer, F. (1994) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)90017-5 · Cited by 662 · cited 1×
“MDD patients were treated with citalopram (dose 33.6± 9.2 mg/day, mean±SD) and supportive counselling (usual treatment) for 8 weeks, starting after the initial dexamethasone suppression-corticotropin releasing hormone stimulation (DEX-CRH) test [ 34 ].”
MethodInfluentialSanacora, G., Mason, G. F., Rothman, D. L., Behar, K. L., Hyder, F., Petroff, O. A. C., Berman, R. M., Charney, D. S., & Krystal, J. H. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.11.1043 · Cited by 627 · cited 1×
“In vivo, proton magnetic resonance spectroscopy (MRS) techniques have repeatedly shown reduced GABA levels in the dorsomedial and anterolateral prefrontal cortex [1] and in the occipital cortex [19–22] of medication-free unipolar MDD patients.”
BackgroundRole of GABA in anxiety and depression
Kalueff, A. V., & Nutt, D. J. (2007) · Depression and Anxiety · doi:10.1002/da.20262 · Cited by 534 · cited 2×
“dysfunctional γ-amino butyric acid (GABA) system [1, 2].”
BackgroundThe Human Brain: Surface, Three-Dimensional Sectional Anatomy with MRI, and Blood Supply
Duvernoy, H. M., Bourgouin, P. M., & Vannson, J. L. (1999) · Cited by 514
Increased Cortical GABA Concentrations in Depressed Patients Receiving ECT
Sanacora, G., Mason, G. F., Rothman, D. L., Hyder, F., Ciarcia, J. J., Ostroff, R. B., Berman, R. M., & Krystal, J. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.3.577 · Cited by 513 · cited 1×
“[20, 26] found an increase in occipital GABA levels, but not after 12 weeks of cognitive behavioural therapy, suggesting state- and treatment-type related changes [27].”
BackgroundSanacora, G., Mason, G. F., Rothman, D. L., & Krystal, J. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.4.663 · Cited by 494 · cited 2×
“In vivo, proton magnetic resonance spectroscopy (MRS) techniques have repeatedly shown reduced GABA levels in the dorsomedial and anterolateral prefrontal cortex [1] and in the occipital cortex [19–22] of medication-free unipolar MDD patients.”
BackgroundMerali, Z., Du, L., Hrdina, P., Palkovits, M., Faludi, G., Poulter, M. O., & Anisman, H. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4734-03.2004 · Cited by 400
Malizia, A. L., Cunningham, V. J., Bell, C. J., Liddle, P. F., Jones, T., & Nutt, D. J. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.8.715 · Cited by 361
Bhagwagar, Z., Wylezinska, M., Jezzard, P., Evans, J., Ashworth, F., Sule, A., Matthews, P. M., & Cowen, P. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.048 · Cited by 303
GABA levels in CSF of patients with psychiatric disorders
(1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.3.362 · Cited by 270 · cited 1×
“In cerebrospinal fluid, reduced GABA has been found in some studies [8–10], but not in others [11–13].”
ResultStress Responsive Neurohormones in Depression and Anxiety
(2003) · Pharmacopsychiatry · doi:10.1055/s-2003-45132 · Cited by 264 · cited 1×
“Moreover, in MDD, hyperactivity of the hypothalamicpituitary-adrenocortical (HPA) axis during an episode is one of the most consistent laboratory findings [3], and has been shown to be related to both its course [4] and treatment outcome [5].”
BackgroundEffects of statistical noise on graphic analysis of PET neuroreceptor studies.
Slifstein, M., & Laruelle, M. A. (2000) · PubMed · Cited by 229
Bhagwagar, Z., Wylezinska, M., Taylor, M., Jezzard, P., Matthews, P. M., & Cowen, P. J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.368 · Cited by 227 · cited 1×
“[61] showed that citalopram itself does not exhibit a direct effect upon the GABAA receptor, though it may indirectly increase the amount of available GABA.”
Background(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.12.1533 · Cited by 212 · cited 1×
“In cerebrospinal fluid, reduced GABA has been found in some studies [8–10], but not in others [11–13].”
ResultBhagwagar, Z., Wylezinska, M., Jezzard, P., Evans, J., Boorman, E., M. Matthews, P., & J. Cowen, P. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007924 · Cited by 186 · cited 1×
“After recovery, prefrontal GABA levels were comparable with those in healthy controls [23], whereas occipital and anterior cingulate cortex GABA levels were still diminished [24, 25].”
ResultMiklós, I. H., & Kovács, K. J. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00147-1 · Cited by 182
Boellaard, R., van Lingen, A., van Balen, S. C. M., Hoving, B. G., & Lammertsma, A. A. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590000405 · Cited by 176 · cited 1×
“During the scan, arterial whole blood was monitored continuously using an online detection system [35].”
MethodSelf-citationAihara, M., Ida, I., Yuuki, N., Oshima, A., Kumano, H., Takahashi, K., Fukuda, M., Oriuchi, N., Endo, K., Matsuda, H., et al. (2007) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2006.11.002 · Cited by 170 · cited 1×
“[48], showing glucose hypermetabolism in the right parahippocampal gyrus in unmedicated MDD patients.”
BackgroundAppelhof, B. C., Huyser, J., Verweij, M., Brouwer, J. P., van Dyck, R., Fliers, E., Hoogendijk, W. J. G., Tijssen, J. G. P., Wiersinga, W. M., & Schene, A. H. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.008 · Cited by 154 · cited 1×
“dysfunctional γ-amino butyric acid (GABA) system [1, 2]. Moreover, in MDD, hyperactivity of the hypothalamicpituitary-adrenocortical (HPA) axis during an episode is one of the most consistent laboratory findings [3], and has been shown to be related to both its course [ 4 ] and treatment outcome [5].”
BackgroundSelf-citationBrouwer, J. P., Appelhof, B. C., van Rossum, E. F. C., Koper, J. W., Fliers, E., Huyser, J., Schene, A. H., Tijssen, J. G. P., van Dyck, R., Lamberts, S. W. J., et al. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2006.08.001 · Cited by 124 · cited 1×
“dysfunctional γ-amino butyric acid (GABA) system [1, 2]. Moreover, in MDD, hyperactivity of the hypothalamicpituitary-adrenocortical (HPA) axis during an episode is one of the most consistent laboratory findings [3], and has been shown to be related to both its course [4] and treatment outcome [ 5 ].”
BackgroundSelf-citationHasler, G., Neumeister, A., van der Veen, J. W. C., Tumonis, T., Bain, E., Shen, J., Drevets, W. C., & Charney, D. S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.017 · Cited by 122 · cited 1×
“After recovery, prefrontal GABA levels were comparable with those in healthy controls [23], whereas occipital and anterior cingulate cortex GABA levels were still diminished [24, 25].”
ResultSanacora, G., Fenton, L. R., Fasula, M. K., Rothman, D. L., Levin, Y., Krystal, J. H., & Mason, G. F. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.015 · Cited by 117 · cited 1×
“[20, 26] found an increase in occipital GABA levels, but not after 12 weeks of cognitive behavioural therapy, suggesting state- and treatment-type related changes [27].”
BackgroundCerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders.
Kasa, K., Otsuki, S., Yamamoto, M., Sato, M., Kuroda, H., & Ogawa, N. (1982) · PubMed · Cited by 117
Orchinik, M., Weiland, N. G., & McEwen, B. S. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00118-c · Cited by 108
Low plasma γ-aminobutyric acid levels in male patients with depression
Petty, F., Kramer, G. L., Gullion, C. M., & Rush, A. J. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90039-3 · Cited by 103 · cited 1×
“Petty et al. [ 7 ] demonstrated that male MDD patients exhibit 10–15% lower total plasma GABA levels than controls.”
BackgroundHasler, G., Nugent, A. C., Carlson, P. J., Carson, R. E., Geraci, M., & Drevets, W. C. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.10.1166 · Cited by 101
Cheetham, S. C., Crompton, M. R., Katona, C., Parker, S. J., & Horton, R. W. (1988) · Brain Research · doi:10.1016/0006-8993(88)91211-5 · Cited by 101
Neuropsychiatric Effects of Insular Stroke
MANES, F., PARADISO, S., & ROBINSON, R. G. (1999) · The Journal of Nervous & Mental Disease · doi:10.1097/00005053-199912000-00001 · Cited by 96 · cited 1×
“Involvement of the insular area in MDD patients, as suggested by the inverse relationship with HPA axis activity found in this study, has been reported in poststroke depression [50], in panic disorder [51], and more recently by both Cameron et al.”
ResultFrancis, P. T., Poynton, A., Lowe, S. L., Najlerahim, A., Bridges, P. K., Bartlett, J. R., PROCTER, A. W., Bruton, C. J., & Bowen, D. M. (1989) · Brain Research · doi:10.1016/0006-8993(89)90600-8 · Cited by 96
Amino acid levels in depression: A preliminary investigation
Honig, A., Bartlett, J. R., Bouras, N., & Bridges, P. K. (1988) · Journal of Psychiatric Research · doi:10.1016/0022-3956(88)90001-5 · Cited by 94 · cited 1×
“[14] found an inverse correlation between depression severity and GABA levels in frontal cortex biopsy tissue of MDD patients resistant to both pharmacotherapy and electroconvulsive therapy (ECT).”
BackgroundCameron, O. G., Huang, G. C., Nichols, T., Koeppe, R. A., Minoshima, S., Rose, D., & Frey, K. A. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.7.793 · Cited by 90
KUIKKA, J. T., PITKÄNEN, A., LEPOLA, U., PARTANEN, K., VAINIO, P., BERGSTRÖM, K. A., WIELER, H. J., KAISER, K. P., MITTELBACH, L., KOPONEN, H., et al. (1995) · Nuclear Medicine Communications · doi:10.1097/00006231-199504000-00159 · Cited by 85 · cited 1×
“Most previous studies [51, 52, 58, 59] did not find correlations between anxiety symptom scores and benzodiazepine binding.”
BackgroundReduction in basal afternoon plasma ACTH during early treatment of depression with fluoxetine
Inder, W. J., Prickett, T. C. R., Joyce, P. R., Mulder, R., & Donald, R. A. (2001) · Psychopharmacology · doi:10.1007/s002130100737 · Cited by 82 · cited 1×
“have been partly mediated by direct effects of citalopram on HPA axis functioning [ 62 ].”
BackgroundHeterogeneity of Hippocampal GABAAReceptors: Regulation by Corticosterone
Orchinik, M., Carroll, S. S., Li, Y.-H., McEwen, B. S., & Weiland, N. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-01-00330.2001 · Cited by 75
SPECT and neuropsychological performance in severe depression treated with ECT
Mervaala, E., Könönen, M., Föhr, J., Husso, M., Valkonen‐Korhonen, M., Kuikka, J. T., Viinamäki, H. T., Tammi, A.-K., Tiihonen, J., Partanen, J., et al. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00288-3 · Cited by 69 · cited 1×
“[28] found an increase in baseline brain [I]iomazenil uptake in severe depression, though not in the temporal cortices.”
BackgroundCSF GABA in depressed patients and normal controls
Roy, A., Dejong, J., & Ferraro, T. (1991) · Psychological Medicine · doi:10.1017/s0033291700022248 · Cited by 66 · cited 1×
“In cerebrospinal fluid, reduced GABA has been found in some studies [8–10], but not in others [11–13].”
ResultCerebral benzodiazepine receptors in depressed patients measured with [123i]iomazenil SPECT
Kugaya, A., Sanacora, G., Verhoeff, N. P. L. G., Fujita, M., Mason, G. F., Seneca, N. M., Bozkurt, A., Khan, S. A., Anand, A., Degen, K. C., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01788-2 · Cited by 63
GABA concentrations in forebrain areas of suicide victims
Korpi, E. R., Kleinman, J. E., & Wyatt, R. J. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90079-0 · Cited by 58 · cited 1×
“In post-mortem brain tissue of depressive suicide victims, Korpi et al. [ 16 ] found no differences in GABA levels in the frontal cortex, basal ganglia, amygdala and hypothalamus when compared to controls.”
ResultComparison of Plasma Input and Reference Tissue Models for Analysing [11C]flumazenil Studies
Klumpers, U. M., Veltman, D. J., Boellaard, R., Comans, E. F., Zuketto, C., Yaqub, M., Mourik, J. E., Lubberink, M., Hoogendijk, W. J., & Lammertsma, A. A. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600554 · Cited by 57
Self-citationRelationships between trait and state anxiety and the central benzodiazepine receptor: a PET study
Abadie, P., Boulenger, J. P., Benali, K., Barré, L., Zarifian, E., & Baron, J. C. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00556.x · Cited by 53 · cited 1×
“[60] and Hasler et al.”
Cerebrospinal fluid GABA in normals and patients with affective disorders
Post, R. M., Ballenger, J. C., Hare, T. A., Goodwin, F. K., Lake, C. R., Jimerson, D. C., & Bunney, W. E. (1980) · Brain Research Bulletin · doi:10.1016/0361-9230(80)90124-0 · Cited by 50 · cited 1×
“In cerebrospinal fluid, reduced GABA has been found in some studies [8–10], but not in others [11–13].”
ResultSchuitemaker, A., van Berckel, B. N. M., Kropholler, M. A., Veltman, D. J., Scheltens, P., Jonker, C., Lammertsma, A. A., & Boellaard, R. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.02.013 · Cited by 35
Self-citationLuthra, S. K., Osman, S., Turton, D. R., Vaja, V., Dowsett, K., & Brady, F. (1993) · Journal of Labelled Compounds and Radiopharmaceuticals · Cited by 32
Increased benzodiazepine receptor density in the prefrontal cortex in patients with panic disorder
Brandt, C., Meller, J., Keweloh, L., Höschel, K., Staedt, J., Munz, D. L., & Stoppe, G. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050134 · Cited by 31 · cited 1×
“Most previous studies [51, 52, 58, 59] did not find correlations between anxiety symptom scores and benzodiazepine binding.”
BackgroundBenzodiazepine binding sites in amygdala and hippocampus of depressed suicide victims
Stocks, G. M., Cheetham, S. C., Crompton, M. R., Katona, C., & Horton, R. W. (1990) · Journal of Affective Disorders · doi:10.1016/0165-0327(90)90112-l · Cited by 29 · cited 1×
“No difference in number or affinity of benzodiazepine binding sites has been reported in the amygdala or hippocampus [18].”
BackgroundZimmer, R., Teelken, A. W., Meier, K. D., Ackenheil, M., & Zander, K. J. (1981) · Progress in Neuro-Psychopharmacology · doi:10.1016/0364-7722(81)90103-x · Cited by 24 · cited 1×
“In cerebrospinal fluid, reduced GABA has been found in some studies [8–10], but not in others [11–13].”
ResultStruys, E. A., Guérand, W. S., ten Brink, H. J., & Jakobs, C. (1999) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(99)00283-2 · Cited by 15
Research works printed but not linked: 1
- Spielberger CD, Gorsuch RL, Lushene RE. STAI manual. Palo Alto, California: Consulting Psychologists Press; 1970.
Cited by
The GABA system in anxiety and depression and its therapeutic potential
Möhler, H. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.040 · Cited by 590
“2) Cortical GABAA receptors and cortical GABA neurons are reduced in major depression (Klumpers et al., 2010; Rajkowska et al., 1999, 2007)”
BackgroundMethodStructural and functional neuroimaging studies of the suicidal brain
Desmyter, S., van Heeringen, C., & Audenaert, K. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.12.026 · Cited by 215
“The inverse relationship between GABAA binding in the temporal lobe and HPA axis activity, suggests that HPA axis hyperactivity is partly due to reduced GABAergic inhibition (Klumpers et al., 2010).”
BackgroundFuchs, T., Jefferson, S. J., Hooper, A., Yee, P.-H., Maguire, J., & Luscher, B. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.188 · Cited by 204
“Conversely, MDD is also associated with reduced concentrations of GABA 5–10 , reduced expression of GABA type A receptors (GABA A Rs) 11 , reduced expression of glutamic acid decarboxylase (GAD) 12, 13 and impaired function of certain subtypes of GABAergic interneurons 14–16 .”
Ghosal, S., Hare, B. D., & Duman, R. S. (2017) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2016.09.012 · Cited by 199
Convergent Mechanisms Underlying Rapid Antidepressant Action
Zanos, P., Thompson, S. M., Duman, R. S., Zarate, C. A., & Gould, T. D. (2018) · CNS Drugs · doi:10.1007/s40263-018-0492-x · Cited by 171
Metadata
- Authors
- Klumpers, U. M. H., Veltman, D. J., Drent, M. L., Boellaard, R., Comans, E. F. I., Meynen, G., Lammertsma, A. A., & Hoogendijk, W. J. G.
- Affiliations
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Amsterdam Neuroscience (NL)
- Corresponding author
- Klumpers, Ursula M. H.
- ORCID
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2009-11-05
- Volume
- 37
- Issue
- 3
- Pages
- 565-574
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- OpenAlex
- W2084145713
- Cited by
- 95
- References
- 66
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 2 · 2023: 6 · 2022: 3 · 2021: 9 · 2020: 3 · 2019: 9 · 2018: 5 · 2017: 9 · 2016: 7 · 2015: 3 · 2014: 5 · 2013: 8 · 2012: 9
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- green
- research.vumc.nl
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Nuclear Medicine and Molecular Imaging (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- VU Research Portal (submittedVersion, other-oa)
- Funders
- ZonMw
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- major depressive disorder, GABAA receptor, [11C]flumazenil, parahippocampal gyrus, HPA axis hyperactivity, citalopram, plasma GABA, insula, dorsolateral prefrontal cortex, temporal lobe, antidepressant response
- MeSH terms
- Adult, Antidepressive Agents, Carbon Radioisotopes, Corticotropin-Releasing Hormone, Major Depressive Disorder, Depressive Disorder, Major, Dexamethasone, Female, Flumazenil, gamma-Aminobutyric Acid, Humans, Male, Neurosecretory Systems, Protein Binding, Receptors, GABA-A, Case-Control Studies, Treatment Outcome, Parahippocampal Gyrus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.